CoChat

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers

Open access
Laskin, Janessa, Jones, Steven, Aparicio, Samuel, Chia, Stephen, Ch'ng, Carolyn, Deyell, Rebecca, Eirew, Peter, Fok, Alexandra, Gelmon, Karen, Ho, Cheryl, Huntsman, David, Jones, Martin, Kasaian, Katayoon, Karsan, Aly, Leelakumari, Sreeja, Li, Yvonne, Lim, Howard, Ma, Yussanne, Mar, Colin, Martin, Monty, Moore, Richard, Mungall, Andrew, Mungall, Karen, Pleasance, Erin, Rassekh, S. Rod, Renouf, Daniel, Shen, Yaoqing, Schein, Jacqueline, Schrader, Kasmintan, Sun, Sophie, Tinker, Anna, Zhao, Eric, Yip, Stephen, Marra, Marco A. · 2015 · Molecular Case Studies
Cited by 109

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Given the success of targeted agents in specific populations it is expected that some degree of molecular biomarker testing will become standard of care for many, if not all, cancers. To facilitate this, cancer centers worldwide are experimenting with targeted “panel” sequencing of selected mutations. Recent advances in genomic technology enable the generation of genome-scale data sets for individual patients. Recognizing the risk, inherent in panel sequencing, of failing to detect meaningful somatic alterations, we sought to establish processes to integrate data from whole-genome analysis (WGA) into routine cancer care. Between June 2012 and August 2014, 100 adult patients with incurable cancers consented to participate in the Personalized OncoGenomics (POG) study. Fresh tumor and blood samples were obtained and used for whole-genome and RNA sequencing. Computational approaches were used to identify candidate driver mutations, genes, and pathways. Diagnostic and drug information were then sought based on these candidate “drivers.” Reports were generated and discussed weekly in a multidisciplinary team setting. Other multidisciplinary working groups were assembled to establish guidelines on the interpretation, communication, and integration of individual genomic findings into patient care. Of 78 patients for whom WGA was possible, results were considered actionable in 55 cases. In 23 of these 55 cases, the patients received treatments motivated by WGA. Our experience indicates that a multidisciplinary team of clinicians and scientists can implement a paradigm in which WGA is integrated into the care of late stage cancer patients to inform systemic therapy decisions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/mcs.a000570

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 109

Metadata

Authors
Laskin, J., Jones, S., Aparicio, S., Chia, S., Ch'ng, C., Deyell, R., Eirew, P., Fok, A., Gelmon, K., Ho, C., Huntsman, D., Jones, M., Kasaian, K., Karsan, A., Leelakumari, S., Li, Y., Lim, H., Ma, Y., Mar, C., Martin, M., Moore, R., Mungall, A., Mungall, K., Pleasance, E., Rassekh, S. R., Renouf, D., Shen, Y., Schein, J., Schrader, K., Sun, S., Tinker, A., Zhao, E., Yip, S., & Marra, M. A.
Venue
Molecular Case Studies
Published
2015-09-24
Volume
1
Issue
1
Pages
a000570
ISSN
  • 2373-2865 (ISSN-L)
  • 2373-2873
OpenAlex
W2276803021
Cited by
109
References
4
Type
posted content
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers. https://app.cochat.ai/papers/10.1101/mcs.a000570
The paper
Laskin, J., Jones, S., Aparicio, S., Chia, S., Ch'ng, C., Deyell, R., Eirew, P., Fok, A., Gelmon, K., Ho, C., Huntsman, D., Jones, M., Kasaian, K., Karsan, A., Leelakumari, S., Li, Y., Lim, H., Ma, Y., Mar, C., . . . Marra, M. A. (2015). Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers. Molecular Case Studies. https://doi.org/10.1101/mcs.a000570

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.